semaglutide biologic A new study from UC San Diego offers early clinical evidence that semaglutide, a widely used GLP-1 receptor agonist, may slow biological aging. In a randomized, placebo-controlled trial, researchers observed a 9% GLP-1 Drugs and the Physiology

10.1016/j.molcel.2011.11.009 42 KadykL

Patients should receive comprehensive injection technique training, including proper subcutaneous administration in the abdomen, thigh, or upper arm, with site rotation to prevent lipohypertrophy

Dermatologists believe this hair loss is caused by the sudden weight loss people go through on these drugs

For commercially insured patients: Wegovy or Zepbound with a manufacturer savings card at $25 per fill

They found that overexpression of miR-145 led to inhibition of IGF-1-induced cell proliferation and miR-145 was shown to directly bind to 3UTR of IGF-1R and IRS-1 in the bladder cancer cells

to avoid disrupting circadian rhythms